相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease
Natalia Carrillo-Lopez et al.
KIDNEY INTERNATIONAL (2016)
Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients
P. Evenepoel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Soluble α-Klotho Serum Levels in Chronic Kidney Disease
Silverio Rotondi et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2015)
High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study
Christiane Drechsler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Osteocytic Protein Expression Response to Doxercalciferol Therapy in Pediatric Dialysis Patients
Renata C. Pereira et al.
PLOS ONE (2015)
Altered Osteocyte-Specific Protein Expression in Bone after Childhood Solid Organ Transplantation
Renata C. Pereira et al.
PLOS ONE (2015)
Relationship Between Serum Sclerostin, Bone Metabolism Markers, and Bone Mineral Density in Maintenance Hemodialysis Patients
Eiji Ishimura et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Serum Sclerostin and Adverse Outcomes in Nondialyzed Chronic Kidney Disease Patients
Mehmet Kanbay et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Renal Elimination of Sclerostin Increases With Declining Kidney Function
Daniel Cejka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Sclerostin Blood Levels Before and After Kidney Transplantation
Marco Bonani et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2014)
Uremic toxicity and sclerostin in chronic kidney disease patients
Lucie Desjardins et al.
NEPHROLOGIE & THERAPEUTIQUE (2014)
Sclerostin and Dickkopf-1 in Post-menopausal Renal Allograft Recipients
P. Tomei et al.
TRANSPLANTATION PROCEEDINGS (2014)
The Relation between Renal Function and Serum Sclerostin in Adult Patients with CKD
Solenne Pelletier et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study
Ivana Pavik et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Laboratory aspects of circulating α-Klotho
Annemieke C. Heijboer et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium
Zachary C. Ryan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
Vincent M. Brandenburg et al.
BMC NEPHROLOGY (2013)
Sclerostin and Its Association with Physical Activity, Age, Gender, Body Composition, and Bone Mineral Content in Healthy Adults
Karin Amrein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients
Daniel Cejka et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Sclerostin and Dickkopf-1 in Renal Osteodystrophy
Daniel Cejka et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Regulation of Circulating Sclerostin Levels by Sex Steroids in Women and in Men
Ulrike Il Moedder et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men
Ulrike I. Moedder et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
The bone and the kidney
Sandro Mazzaferro et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
The syndromic status of sclerosteosis and van Buchem disease
P. Beighton et al.
CLINICAL GENETICS (2010)
The Fibroblast Growth Factor 23: A New Player in the Field of Cardiovascular, Bone and Renal Disease
Mario Cozzolino et al.
CURRENT VASCULAR PHARMACOLOGY (2010)
Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women
Faryal S. Mirza et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Augmented Wnt signaling in a mammalian model of accelerated aging
Hongjun Liu et al.
SCIENCE (2007)
Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors
Stephen J. Rodda et al.
DEVELOPMENT (2006)
Pathogenic role of Fgf23 in Hyp mice
Shiguang Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D
Shiguang Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulation of osteoblastogenesis and bone mass by Wnt10b
CN Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST)
B Sevetson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The natural history of sclerosteosis
H Hamersma et al.
CLINICAL GENETICS (2003)
FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate
AE Bowe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
分享论文
